Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines.
Crockford D, Bahji A, Schutz C, Brasch J, Buckley L, Danilewitz M, Dubreucq S, Mak M, George TP. Crockford D, et al. Can J Psychiatry. 2024 Jun;69(6):457-478. doi: 10.1177/07067437241232456. Epub 2024 Mar 27. Can J Psychiatry. 2024. PMID: 38533564 No abstract available.
Effect of scattered-site housing using rent supplements and intensive case management on housing stability among homeless adults with mental illness: a randomized trial.
Stergiopoulos V, Hwang SW, Gozdzik A, Nisenbaum R, Latimer E, Rabouin D, Adair CE, Bourque J, Connelly J, Frankish J, Katz LY, Mason K, Misir V, O'Brien K, Sareen J, Schütz CG, Singer A, Streiner DL, Vasiliadis HM, Goering PN; At Home/Chez Soi Investigators. Stergiopoulos V, et al. Among authors: schutz cg. JAMA. 2015 Mar 3;313(9):905-15. doi: 10.1001/jama.2015.1163. JAMA. 2015. PMID: 25734732 Clinical Trial.
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Bakouni H, Sharafi H, Bahremand A, Drouin S, Ziegler D, Bach P, Le Foll B, Schütz CG, Tardelli V, Ezard N, Siefried K, Jutras-Aswad D. Bakouni H, et al. Among authors: schutz cg. Drug Alcohol Depend. 2023 Dec 1;253:111018. doi: 10.1016/j.drugalcdep.2023.111018. Epub 2023 Nov 4. Drug Alcohol Depend. 2023. PMID: 37979478 Review.
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sharafi H, Bakouni H, McAnulty C, Drouin S, Coronado-Montoya S, Bahremand A, Bach P, Ezard N, Le Foll B, Schütz CG, Siefried KJ, Tardelli VS, Ziegler D, Jutras-Aswad D. Sharafi H, et al. Among authors: schutz cg. Addiction. 2024 Feb;119(2):211-224. doi: 10.1111/add.16347. Epub 2023 Oct 25. Addiction. 2024. PMID: 37880829 Review.
Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
Rafizadeh R, Frankow L, Mahmood H, Poonia S, Mathew N, Danilewitz M, Bousman CA, Honer WG, Schütz CG. Rafizadeh R, et al. Among authors: schutz cg. J Psychopharmacol. 2023 Oct;37(10):1040-1048. doi: 10.1177/02698811231191781. Epub 2023 Aug 4. J Psychopharmacol. 2023. PMID: 37539972 Free PMC article.
69 results